SCHEMBL7513571

SCHEMBL7513571

Cc1ccc(C)c(C(=O)c2ccc(SNc3cccc4ccn(C)c34)cc2Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 8/20 0.37
MAPK12 P53778 8/20 0.37
MAPK11 Q15759 8/20 0.37
MAPK14 Q16539 8/20 0.37
PPARG P37231 2/20 0.35
PPARD Q03181 2/20 0.35
PPARA Q07869 2/20 0.35
MAPK1 P28482 2/20 0.34
ALOX15 P16050 1/20 0.34
RAB9A P51151 2/20 0.33
LMNA P02545 2/20 0.33
MITF O75030 1/20 0.33
S1PR4 O95977 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
S1PR1 P21453 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7516093 0.90 MAPK13 (0.47) MAPK13MAPK12MAPK11MAPK14MAPK1
SCHEMBL7518627 0.88 SMN1; SMN2 (0.40) MAPK13MAPK12MAPK11MAPK14RAB9A
SCHEMBL7514848 0.83 MAPK14 (0.54) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL7035322 0.77 MAPK13 (0.38) MAPK13MAPK12MAPK11MAPK14MAPK1
SCHEMBL7030642 0.75 KDM4C (0.44) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL7509072 0.73 MAPK14 (0.53) MAPK13MAPK12MAPK11MAPK14SMN1; SMN2
SCHEMBL7510773 0.73 MAPK14 (0.68) MAPK13MAPK12MAPK11MAPK14LMNA
SCHEMBL7513578 0.72 MAPK14 (0.41) MAPK13MAPK12MAPK11MAPK14PPARG
SCHEMBL7514380 0.71 MAPK13 (0.48) MAPK13MAPK12MAPK11MAPK14MAPK1
SCHEMBL7596971 0.71 CMA1 (0.40) MAPK13MAPK12MAPK11MAPK14RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US claimed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US claimed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA MAPK13 1908/4885MAPK12 1184/4885MAPK11 2116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.